pharmacie et médicaments – Conséquences de l'arrêté relatif aux remises des médicaments génériques

This written question concerns the consequences of a decree on rebates for generic medicines in France. It seeks clarification on the impact of these rebates on the pharmaceutical market and access to medicines. The question is addressed to the French government and likely affects pharmaceutical companies, pharmacies, and patients who rely on generic medications.